- Home
- SVRA vs EU Comparison
SVRA vs EU Comparison
Compare SVRA & EU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- EU
- Stock Information
- Founded
- SVRA 2007
- EU 2009
- Country
- SVRA United States
- EU United States
- Employees
- SVRA N/A
- EU N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- EU Other Metals and Minerals
- Sector
- SVRA Health Care
- EU Basic Materials
- Exchange
- SVRA Nasdaq
- EU Nasdaq
- Market Cap
- SVRA 473.6M
- EU 538.3M
- IPO Year
- SVRA N/A
- EU N/A
- Fundamental
- Price
- SVRA $3.04
- EU $2.74
- Analyst Decision
- SVRA Buy
- EU Strong Buy
- Analyst Count
- SVRA 7
- EU 1
- Target Price
- SVRA $5.57
- EU $4.00
- AVG Volume (30 Days)
- SVRA 1.1M
- EU 2.2M
- Earning Date
- SVRA 08-13-2025
- EU 08-11-2025
- Dividend Yield
- SVRA N/A
- EU N/A
- EPS Growth
- SVRA N/A
- EU N/A
- EPS
- SVRA N/A
- EU N/A
- Revenue
- SVRA N/A
- EU $44,524,000.00
- Revenue This Year
- SVRA N/A
- EU $33.42
- Revenue Next Year
- SVRA N/A
- EU $104.87
- P/E Ratio
- SVRA N/A
- EU N/A
- Revenue Growth
- SVRA N/A
- EU N/A
- 52 Week Low
- SVRA $1.89
- EU $1.01
- 52 Week High
- SVRA $4.70
- EU $4.44
- Technical
- Relative Strength Index (RSI)
- SVRA 69.39
- EU 49.88
- Support Level
- SVRA $2.43
- EU $2.60
- Resistance Level
- SVRA $2.77
- EU $2.90
- Average True Range (ATR)
- SVRA 0.20
- EU 0.18
- MACD
- SVRA 0.04
- EU -0.02
- Stochastic Oscillator
- SVRA 71.76
- EU 52.24
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About EU enCore Energy Corp.
enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties of uranium resource properties in the United States. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's Projects are South Texas Operations, Dewey-Burdock Project, Gas Hills Project, Crownpoint & Hosta Butte Project, PFN (Prompt Fission Neutron) Technology, and Other Assets.